Aspen in talks to make and sell J&J vaccines for Africa
Africa aims to vaccinate 60% of its adult population by 2022
05 September 2021 - 00:09
Aspen Pharmacare says it is in talks to make Johnson & Johnson's coronavirus shot under licence in SA, at what would be Africa's first major independent distribution base for a global vaccine against Covid-19.
News of the talks coincided with the suspension of the heavily criticised shipment to Europe from Africa of the same shot, which is already being made under contract and packaged by Aspen, but distributed by J&J...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.